Research ID
hum0561-v1Release info
Research title
A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical Outcome in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Enzalutamide
Research overview
- Aims
- The association between tumor genomic alterations and clinical outcomes, including clinical and radiographic progression-free survival, PSA response, PSA progression-free survival, overall survival, and time to progression to castration-resistant prostate cancer (CRPC), was investigated in patients with metastatic castration sensitive prostate cancer (mCSPC) treated with the oral nonsteroidal antiandrogen enzalutamide. The findings are expected to contribute to the development of novel therapeutic strategies for personalized medicine in prostate cancer.
- Methods
- Whole exome sequencing analysis
- Participants/materials
- 76 mCSPCs prior to enzalutamide treatment
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD001046 | NGS (Exome) |
| Controlled-access (Type I) | 2026-05-26 |
Data provider
- Principal investigator
- Koji Hatano
- Affiliation
- Department of Urology, The University of Osaka Graduate School of Medicine
Research projects
| Name | URL |
|---|---|
MENZ study group | N/A |
Grants
| Name | Title | Project number |
|---|---|---|
Cancer Clinical Research Grant Program | A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical Outcome in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Enzalutamide | N/A |
Astellas funding | A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical Outcome in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Enzalutamide | N/A |
Related publications
No related publications.
Controlled access users
No use of the controlled access data has been recorded.